Casatenovo, Italy

Bruno Gaetano Romano

This inventor holds 1 USPTO granted patent. Top assignee: Quimica Sintetica, S.a.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Gaetano Romano. Retrieved from https://idiyas.com/inventor/bruno-gaetano-romano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bruno Gaetano Romano

Introduction

Bruno Gaetano Romano is an accomplished inventor based in Casatenovo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. His innovative approach has led to the development of a unique process that enhances the efficiency of drug preparation.

Latest Patents

Romano holds a patent for a process for the preparation of (1S,2R)-Milnacipran. This invention relates to the preparation of Levomilnacipran or its salts, which are compounds useful in treating depression. The process is notable for its high yield, making it a valuable advancement in pharmaceutical manufacturing. He has 1 patent to his name.

Career Highlights

Romano is associated with Quimica Sintetica, S.A., where he applies his expertise in chemical processes. His work has been instrumental in advancing the company's capabilities in drug development. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Romano collaborates with Giuseppe Barreca, a fellow professional in the industry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research and development.

Conclusion

Bruno Gaetano Romano's contributions to the pharmaceutical industry highlight the impact of innovative processes in drug preparation. His work not only advances scientific knowledge but also improves treatment options for patients suffering from depression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…